Site name unknown, Milan

Phase	Trial [desc]	Trial Status	Site Status	Drug	NCT#
2	Treatment of Patients With RAD001 Who Have Progressive Sarcoma	Completed	Closed	Everolimus	NCT00767819
2	Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib. (OPEN)	Active, not recruiting	Closed	Nilotinib	NCT00756509
1	Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer	Terminated	Closed	PF-052112384 + PD-0325901 OR PF-052112384 + Irinotecan	NCT01347866
1/2	Phase I/II Study of PDR001 in Patients With Advanced Malignancies	Active, not recruiting	Closed	PDR001	NCT02404441
2	Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib (DoviGIST)	Completed	Active	Dovitinib	NCT01478373
2	A Study of IMC-3G3 in Previously Treated Patients With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors	Terminated	Closed	Olaratumab (IMC-3G3)	NCT01316263